Wolverine Blend Research Guide
A two-component BPC-157 and TB-500 research blend in 10 mg and 20 mg vials. Summarizes the research on each component and what has not been studied.
What is Wolverine Blend?
Wolverine is a two-component laboratory research blend of BPC-157 and TB-500. Wolverine 10mg contains BPC-157 5 mg and TB-500 5 mg per vial. Wolverine 20mg contains BPC-157 10 mg and TB-500 10 mg per vial.
Both components are synthetic peptides. BPC-157 is a 15-amino-acid partial sequence of body protection compound, a protein reported in human gastric juice (Chang et al., 2011). TB-500 is a synthetic version of LKKTETQ, residues 17 to 23 of thymosin beta-4, with an acetylated N-terminus (Ho et al., 2012). Each has its own guide with the full research summary.
Research areas studied
The findings below come from cell, animal and published clinical research. They describe what studies have examined and reported, not effects of any research material.
BPC-157 research
In rat tendon explants and cultured tendon fibroblasts, BPC-157 increased fibroblast outgrowth, survival under oxidative stress and migration, without directly changing proliferation, and the authors linked this to the FAK-paxillin pathway (Chang et al., 2011). The evidence base is almost entirely animal and cell research. A 2026 systematic review found three small human studies with 30 participants in total and rated the certainty of the human evidence as very low (Poolton et al., 2026).
TB-500 research
The LKKTETQ segment is described as the region of thymosin beta-4 responsible for actin binding and cell migration (Ho et al., 2012). Most biological research uses full-length thymosin beta-4. For example, in a rat full-thickness wound model it increased reepithelialization, collagen deposition and angiogenesis, and it stimulated keratinocyte migration in vitro (Malinda et al., 1999). Peer-reviewed work on the acetylated fragment itself is mainly analytical, such as an LC-MS method developed for equine doping control (Ho et al., 2012).
What has not been studied
We found no peer-reviewed studies of this specific combination. Findings for the individual components do not establish the behavior, stability or effects of a combined preparation, and possible interactions between the two peptides have not been reported in the sources reviewed.
Regulatory status
Neither component is an approved drug. FDA’s compounding safety page lists both BPC-157 and the thymosin beta-4 fragment (LKKTETQ) among nominated bulk substances whose nominations were withdrawn, citing concerns that include possible immunogenicity.
Storage and handling
Like most research blends, Wolverine Blend is normally supplied for laboratory use as a lyophilized (freeze-dried) powder in a sealed vial. Check the label and the batch COA for the exact form of your lot. Zero Zero Collection recommends keeping vials refrigerated at 2 to 8 ยฐC and protected from light, as stated on every product page. Let a refrigerated vial reach room temperature before opening it so moisture does not condense on the powder.
When a lab reconstitutes lyophilized material, standard practice is to add a sterile diluent such as bacteriostatic water slowly down the inside wall of the vial, then swirl gently rather than shake. The volume depends on the concentration a protocol calls for, so follow your own lab’s validated method. Label the vial with the date, keep reconstituted material refrigerated, and follow your institution’s guidance on how long a solution stays usable.
Quality and COA
Every Zero Zero Collection product page has a View COA link. Certificates of analysis come from independent third-party testing by Freedom Diagnostics and are posted on our Quality page where available. A COA reports what the testing lab measured for one specific batch, so match the lot number on your vial to the certificate. Our FAQ explains how to read a COA.
Wolverine Blend FAQ
What is the difference between Wolverine 10mg and Wolverine 20mg?
The ratio is the same. Wolverine 10mg contains BPC-157 5 mg and TB-500 5 mg per vial, and Wolverine 20mg contains BPC-157 10 mg and TB-500 10 mg per vial.
Has the BPC-157 and TB-500 combination been studied?
We found no peer-reviewed studies of this specific combination. The published research covers each component separately.
Are BPC-157 or TB-500 approved drugs?
No. Neither is approved, and FDA lists both among bulk substances whose compounding nominations were withdrawn.
References
- Chang CH, Tsai WC, Lin MS, et al. (2011). J Appl Physiol. PubMed 21030672
- Ho EN, Kwok WH, Lau MY, et al. (2012). J Chromatogr A. PubMed 23084823
- Poolton JT, Minett J, Kazmi A (2026). Acta Orthop Belg. PubMed 42885452
- Malinda KM, Sidhu GS, Mani H, et al. (1999). J Invest Dermatol. PubMed 10469335
- U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. Accessed October 28, 2026. fda.gov
For research use only. Not for human consumption. This guide summarizes published scientific literature for laboratory research context. It is not medical advice, dosing guidance or a claim of safety or effectiveness for any use in people or animals.